A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses

. 2020 Jan 14 ; 12 (1) : . [epub] 20200114

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31947563

Grantová podpora
17-05409S Grantová Agentura České Republiky
CZ.02.1.01/0.0/0.0/16_019/0000841 The ministry of education, youth and sport (CZ)

Quercetin is proven to decrease arterial blood pressure when given orally. Its bioavailability is, however, low and, therefore, its metabolites could rather be responsible for this effect. In particular, the colonic metabolites of quercetin, 3,4-dihydroxyphenylacetic acid (DHPA), 4-methylcatechol (4MC), and 3-(3-hydroxyphenyl)propionic acid (3HPPA), have been previously shown to decrease the blood pressure in spontaneously hypertensive rats (SHR). Interestingly, the mechanisms of action of these three metabolites are different. The aim of this study is hence to investigate if these metabolites can potentiate each other and thus decrease blood pressure in reduced doses. Three double-combinations of previously mentioned metabolites were administered to SHR as infusions to mimic a real biological situation. All combinations significantly decreased the blood pressure in SHR but there were important differences. The effect of DHPA and 4MC was mild and very short. A combination of DHPA with 3HPPA caused more pronounced effects, which were also rather short-lived. The last combination of 3HPPA and 4MC caused a long-lasting effect. In conclusion, certain combinations of quercetin metabolites have a more pronounced antihypertensive effect than single metabolites.

Zobrazit více v PubMed

Perez A., Gonzalez-Manzano S., Jimenez R., Perez-Abud R., Haro J.M., Osuna A., Santos-Buelga C., Duarte J., Perez-Vizcaino F. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity. Pharmacol. Res. 2014;89:11–18. doi: 10.1016/j.phrs.2014.07.005. PubMed DOI

Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 2007;137:2405–2411. doi: 10.1093/jn/137.11.2405. PubMed DOI

Williamson G., Kay C.D., Crozier A. The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective. Compr. Rev. Food Sci. Food Saf. 2018;17:1054–1112. doi: 10.1111/1541-4337.12351. PubMed DOI

Rechner A.R., Smith M.A., Kuhnle G., Gibson G.R., Debnam E.S., Srai S.K., Moore K.P., Rice-Evans C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004;36:212–225. doi: 10.1016/j.freeradbiomed.2003.09.022. PubMed DOI

De Bruyne T., Steenput B., Roth L., De Meyer G.R.Y., Santos C.N.D., Valentova K., Dambrova M., Hermans N. Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism. Nutrients. 2019;11:578. doi: 10.3390/nu11030578. PubMed DOI PMC

Galindo P., Rodriguez-Gomez I., Gonzalez-Manzano S., Duenas M., Jimenez R., Menendez C., Vargas F., Tamargo J., Santos-Buelga C., Perez-Vizcaino F., et al. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS ONE. 2012;7:e32673. doi: 10.1371/journal.pone.0032673. PubMed DOI PMC

Najmanova I., Pourova J., Voprsalova M., Pilarova V., Semecky V., Novakova L., Mladenka P. Flavonoid metabolite 3-(3-hydroxyphenyl) propionic acid formed by human microflora decreases arterial blood pressure in rats. Mol. Nutr. Food Res. 2016;60:981–991. doi: 10.1002/mnfr.201500761. PubMed DOI

Pourova J., Najmanova I., Voprsalova M., Migkos T., Pilarova V., Applova L., Novakova L., Mladenka P. Two flavonoid metabolites, 3,4-dihydroxyphenylacetic acid and 4-methylcatechol, relax arteries ex vivo and decrease blood pressure in vivo. Vasc. Pharmacol. 2018;111:36–43. doi: 10.1016/j.vph.2018.08.008. PubMed DOI

Feliciano R.P., Boeres A., Massacessi L., Istas G., Ventura M.R., Nunes Dos Santos C., Heiss C., Rodriguez-Mateos A. Identification and quantification of novel cranberry-derived plasma and urinary (poly) phenols. Arch. Biochem. Biophys. 2016;599:31–41. doi: 10.1016/j.abb.2016.01.014. PubMed DOI

Margalef M., Iglesias-Carres L., Pons Z., Bravo F.I., Muguerza B., Arola-Arnal A. Age related differences in the plasma kinetics of flavanols in rats. J. Nutr. Biochem. 2016;29:90–96. doi: 10.1016/j.jnutbio.2015.11.007. PubMed DOI

Margalef M., Pons Z., Iglesias-Carres L., Bravo F.I., Muguerza B., Arola-Arnal A. Flavanol plasma bioavailability is affected by metabolic syndrome in rats. Food Chem. 2017;231:287–294. doi: 10.1016/j.foodchem.2017.03.141. PubMed DOI

Conterno L., Martinelli F., Tamburini M., Fava F., Mancini A., Sordo M., Pindo M., Martens S., Masuero D., Vrhovsek U., et al. Measuring the impact of olive pomace enriched biscuits on the gut microbiota and its metabolic activity in mildly hypercholesterolaemic subjects. Eur. J. Nutr. 2019;58:63–81. doi: 10.1007/s00394-017-1572-2. PubMed DOI PMC

Applova L., Karlickova J., Warncke P., Macakova K., Hrubsa M., Machacek M., Tvrdy V., Fischer D., Mladenka P. 4-Methylcatechol, a Flavonoid Metabolite with Potent Antiplatelet Effects. Mol. Nutr. Food Res. 2019;63:e1900261. doi: 10.1002/mnfr.201900261. PubMed DOI

Oudot C., Gomes A., Nicolas V., Le Gall M., Chaffey P., Broussard C., Calamita G., Mastrodonato M., Gena P., Perfettini J.L., et al. CSRP3 mediates polyphenols-induced cardioprotection in hypertension. J. Nutr. Biochem. 2019;66:29–42. doi: 10.1016/j.jnutbio.2019.01.001. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...